Paper39429696
Discovery of plasma biomarkers related to blood-brain barrier dysregulation in Alzheimer's disease.
Dan YR and 1 other. Front Bioinform, 2024. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Discovery of plasma biomarkers related to blood-brain barrier dysregulation in Alzheimer's disease. Papers, record 39429696. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39429696
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Discovery of plasma biomarkers related to blood-brain barrier dysregulation in Alzheimer's disease.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References68
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17077814 | Transport pathways for clearance of human Alzheimer's amyloid beta-peptide and apolipoproteins E and J in the mouse central nervous system. | J Cereb Blood Flow Metab | 2007 | https://conductscience.org/library/papers/17077814 | PubMed |
| 2 | 29500152 | Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study. | Lancet Neurol | 2018 | https://conductscience.org/library/papers/29500152 | PubMed |
| 3 | 24612673 | Apolipoprotein D takes center stage in the stress response of the aging and degenerative brain. | Neurobiol Aging | 2014 | https://conductscience.org/library/papers/24612673 | PubMed |
| 4 | 22287627 | Differential expression analysis of multifactor RNA-Seq experiments with respect to biological variation. | Nucleic Acids Res | 2012 | https://conductscience.org/library/papers/22287627 | PubMed |
| 5 | 26147761 | β2-microglobulin is a systemic pro-aging factor that impairs cognitive function and neurogenesis. | Nat Med | 2015 | https://conductscience.org/library/papers/26147761 | PubMed |
| 6 | 27243267 | Blood-Brain Barrier Leakage in Patients with Early Alzheimer Disease. | Radiology | 2016 | https://conductscience.org/library/papers/27243267 | PubMed |
| 7 | 38347190 | Plasma proteomic profiles predict future dementia in healthy adults. | Nat Aging | 2024 | https://conductscience.org/library/papers/38347190 | PubMed |
| 8 | 35292360 | Clusterin in Alzheimer's disease: An amyloidogenic inhibitor of amyloid formation? | Biochim Biophys Acta Mol Basis Dis | 2022 | https://conductscience.org/library/papers/35292360 | PubMed |
| 9 | 21892414 | Alzheimer's risk variants in the clusterin gene are associated with alternative splicing. | Transl Psychiatry | 2011 | https://conductscience.org/library/papers/21892414 | PubMed |
| 10 | 36138003 | Clusterin transduces Alzheimer-risk signals to amyloidogenesis. | Signal Transduct Target Ther | 2022 | https://conductscience.org/library/papers/36138003 | PubMed |
| 11 | 26243271 | CFH Variants Affect Structural and Functional Brain Changes and Genetic Risk of Alzheimer's Disease. | Neuropsychopharmacology | 2016 | https://conductscience.org/library/papers/26243271 | PubMed |
| 12 | 31882899 | Dynamics of clusterin protein expression in the brain and plasma following experimental traumatic brain injury. | Sci Rep | 2019 | https://conductscience.org/library/papers/31882899 | PubMed |
| 13 | 18458334 | Human ApoD, an apolipoprotein up-regulated in neurodegenerative diseases, extends lifespan and increases stress resistance in Drosophila. | Proc Natl Acad Sci U S A | 2008 | https://conductscience.org/library/papers/18458334 | PubMed |
| 14 | 38049398 | JUN upregulation drives aberrant transposable element mobilization, associated innate immune response, and impaired neurogenesis in Alzheimer's disease. | Nat Commun | 2023 | https://conductscience.org/library/papers/38049398 | PubMed |
| 15 | 28566429 | Complement C3 deficiency protects against neurodegeneration in aged plaque-rich APP/PS1 mice. | Sci Transl Med | 2017 | https://conductscience.org/library/papers/28566429 | PubMed |
| 16 | 31603904 | Characterization of Parkinson's disease using blood-based biomarkers: A multicohort proteomic analysis. | PLoS Med | 2019 | https://conductscience.org/library/papers/31603904 | PubMed |
| 17 | 16632515 | Adjusting batch effects in microarray expression data using empirical Bayes methods. | Biostatistics | 2007 | https://conductscience.org/library/papers/16632515 | PubMed |
| 18 | 35115731 | Large-scale deep multi-layer analysis of Alzheimer's disease brain reveals strong proteomic disease-related changes not observed at the RNA level. | Nat Neurosci | 2022 | https://conductscience.org/library/papers/35115731 | PubMed |
| 19 | 32081424 | Disrupted blood-brain barrier in 5×FAD mouse model of Alzheimer's disease can be mimicked and repaired in vitro with neural stem cell-derived exosomes. | Biochem Biophys Res Commun | 2020 | https://conductscience.org/library/papers/32081424 | PubMed |
| 20 | 33933186 | Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group. | Lancet Neurol | 2021 | https://conductscience.org/library/papers/33933186 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42939332 | Age-Stratified Serum Biomarkers for Discriminating Clinically Defined Cognitive Impairment in Neurological Inpatients: A Cross-Sectional Study. | Brain Sci | 2026 | https://conductscience.org/library/papers/42939332 | PubMed |
| 42774371 | Rat brain phospholipid remodeling correlates with plasma lipid clearance and late functional vulnerability after ischemic stroke. | iScience | 2026 | https://conductscience.org/library/papers/42774371 | PubMed |
| 42340458 | Plasma Biomarkers for Alzheimer's Disease Across the Continuum: A Systematic Review of SIMOA-Based Studies. | Cell Mol Neurobiol | 2026 | https://conductscience.org/library/papers/42340458 | PubMed |
| 41588241 | Exploratory RNA Sequencing Reveals Systemic Metabolic Dysregulation in Alzheimer's Disease: Insights from a Diverse Latin American Cohort. | Mol Neurobiol | 2026 | https://conductscience.org/library/papers/41588241 | PubMed |
| 41465272 | Neurovascular Dysfunction and Glymphatic Impairment: An Unexplored Therapeutic Frontier in Neurodegeneration. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41465272 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| APOD | 347 | PubTator's text mining | https://conductscience.org/library/genes/347 | NCBI Gene |
| B2M | 567 | PubTator's text mining | https://conductscience.org/library/genes/567 | NCBI Gene |
| CFH | 3075 | PubTator's text mining | https://conductscience.org/library/genes/3075 | NCBI Gene |
| CLU | 1191 | PubTator's text mining | https://conductscience.org/library/genes/1191 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39429696
GET https://conductscience.org/api/papers/v1/39429696/references?page=2